AstraZeneca
More News
-
AstraZeneca's Tagrisso plus chemo approved by China for first-line cancer therapy
AstraZeneca says approval by China's NMPA based on trials on patients given combination treatment
-
AstraZeneca, AI biologics firm Absci tie up on cancer drug
AstraZeneca signs deal worth $247 million with AI biologists Absci to design new antibody to fight cancer
-
AstraZeneca China summoned over suspected fraud
The company says some employees had altered or participated in altering patients' testing reports
-
Second batch of AstraZeneca vaccine arrives in Islamabad
The second batch of more than 1.2 million jabs reached Islamabad today
-
Britain hosts G-7 health summit amid pressure to broaden Covid vaccine access
British foreign minister says equitable access to vaccines will be at the top of agenda when G7 leaders meet
-
Covid fight could return ‘to square one’: experts sound vaccines alarm
COVAX, which is critical for poorer countries, relies on AstraZeneca shots made by the Serum Institute of India
-
Current Covid vaccines appear protective against variants, WHO Europe says
Official urges authorities in region where Covid was caused by Indian variant to remain vigilant
-
Bangladesh urges India for immediate release of purchased vaccines
New Delhi assures Dhaka it would help get US vaccines on priority basis, says minister
-
India reports 26 'suspected' cases of bleeding, clotting after AstraZeneca vaccine
This is the first time India reported any serious reaction to use of vaccine
-
AstraZeneca not for women under 40: Health Ministry
New guidelines restrict the use of Oxford-AstraZeneca vaccine for women under the age of 40
-
EU legal case against AstraZeneca begins in Brussels court
Cuts and delays in AstraZeneca deliveries have weighed on the choppy inoculation campaign in the bloc
-
Australia flags mass inoculation amid Covid-19 vaccine turmoil
The federal government and to discuss setting up mass vaccination centres from as early as June
-
Britons can be confident in vaccine monitoring, health secretary says
“We have more than enough Pfizer and Moderna vaccines to cover all of the remaining eight and a half million people,”
-
Spain limits AstraZeneca coronavirus vaccine to over 60-year olds
After EU and British regulators found a potential link between the shot and rare brain blood clots
-
AstraZeneca jab has plausible link to blood clots: WHO
Relationship between vaccine, blood clots not confirmed, more studies needed, says WHO advisory committee
-
Australia to continue AstraZeneca vaccine rollout, review EU findings
Australia has no current plans to change the rollout of the AstraZeneca Covid-19 vaccine
-
Oxford pauses Covid-19 vaccine study in kids, awaits more data on blood clot issues
The university said in February it planned to enroll 300 volunteers aged 6-17 years, based in the United Kingdom
-
Seven deaths in UK among AstraZeneca jab recipients after blood clots
British acknowledgement of deaths comes as several European countries paused use of Oxford vaccine
-
UK regulator found total of 30 cases of blood clot events after AstraZeneca vaccine use
Regulatory Agency says no such reports of clotting events following use of BioNTech SE and Pfizer Inc vaccines
-
AstraZeneca counters Indonesian Muslim concerns over Covid-19 vaccine
After the Indonesia Ulema Council said the vaccine manufacturing process uses pork-derived ingredients
-
UK PM Johnson gets his first dose of AstraZeneca vaccine
Johnson, 56, received his vaccine at the same hospital where almost a year ago he was put in an intensive care unit
-
Keep using AstraZeneca vaccine, WHO urges world
Oxford vaccine is important because it accounts for 90% of vaccines being distributed through COVAX, says Tedros
-
Indonesia to resume use of AstraZeneca vaccine after reviewing blood clot concerns
BPOM cautions against the use of AstraZeneca for people with a low blood platelet count and blood clotting disorder
-
US to share 4 million doses of AstraZeneca Covid-19 vaccine with Mexico, Canada
Following pressure from countries around the world on Biden administration to share vaccines
-
Explainer: How worried should we be about reports of blood clots and AstraZeneca's vaccine?
European Medicines Agency says it has so far found no causal link between the vaccine and the incidents
-
German Covid-19 cases are growing exponentially again
“We are exactly on the flank of the third wave. That can no longer be disputed"
-
AstraZeneca further cuts EU vaccine supply target to 30 million
The shortfall is a further blow to the EU’s vaccination plans already being hampered by repeated delays in supply
-
EU must be united over Russian, Chinese Covid-19 vaccines: French minister
Europe has so far approved vaccines from Pfizer/BioNTech, Moderna and AstraZeneca/Oxford
-
Modi's ministers choose 'Made in India' vaccine over AstraZeneca
“Made-in-India vaccines are 100% safe,” Health Minister Harsh Vardhan said after being inoculated with COVAXIN
-
Senior citizens to get vaccine from March 2
9 million elderly people would get anti-Covid jabs through Covax progamme
-
1,050 more people test positive for COVID-19 across country
The active cases in the country total to 24,483; 41 deaths in the past 24 hours
-
Govt decides to inoculate elderly people with AstraZeneca vaccine
Pakistan will commence second phase of immunisation rive from next month, says SAPM Dr Faisal Sultan
-
South Africa to return 1m Covid vaccine doses to Indian drug maker
Clinical trial showed shot offered minimal protection against new coronavirus variant
-
Oxford University to test Covid-19 vaccine response among children for first time
300 volunteers will be enrolled and first inoculations are expected this month
-
WHO expert panel recommends wide use of AstraZeneca Covid vaccine
The recommendation also includes people aged 65 and older
-
UK says Astrazeneca vaccine prevents COVID-19 death as South Africa halts shots
Only a tiny minority are likely to be important or change the virus in an appreciable way says British Medical Journal
-
Britain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen
Initial data on immune responses expected to be generated around June
-
AstraZeneca to supply 9 million more Covid-19 vaccine doses, says EU
Will start deliveries one week earlier than expected
-
PAF plane leaves for China to bring Covid-19 vaccine
NCOC makes arrangements for the vaccine's storage in Islamabad, transportation to provinces.
-
'Good news': Pakistan secures 17m doses of AstraZeneca vaccine
6 to 6.8 million doses of vaccine will be available within first quarter of current year, says SAPM Dr Faisal Sultan
-
Mexico to import AstraZeneca vaccine from India, president says
Mexico also expects about 1.5 million doses from Pfizer after global delivery delays by the US company
-
South Korea reviews AstraZeneca vaccine for elderly under rollout plan
After the government unveiled a plan to inoculate 10 million high-risk people by July
-
EU locks horns with AstraZeneca on vaccine deliveries amid 'supply shock'
AstraZeneca told the EU on Friday it could not meet agreed supply targets up to the end of March
-
Bangladesh gets 2 million doses of Oxford vaccine from India
India handed over doses as part of its commitment to 'neighbourhood first policy,' says official
-
Provinces, private entities free to import Covid-19 vaccine, says Asad Umar
NCOC chief says federal govt has from the beginning maintained it does not have monopoly over import of vaccines
-
‘India approves AstraZeneca Covid vaccine, country's first’
India wants to start administering the vaccine soon, most likely by Wednesday, say sources
-
Britain first to approve AstraZeneca/Oxford Covid-19 vaccine
UK battles a major winter surge driven by a new, highly contagious variant of the virus
-
AstraZeneca Covid vaccine has 'winning formula': chief executive
The vaccine provides '100 percent protection' against severe Covid disease requiring hospitalisation
-
UK to roll out Oxford Covid-19 vaccine from Jan 4, Sunday Telegraph says
Govt hopes to give the first dose of Oxford or the Pfizer vaccine to 2 million people over the next two weeks
-
Britain’s AstraZeneca to buy US pharma firm for $39b
Shareholders of Alexion will receive $60 in cash, $115 worth of equity per share